Suraksha Diagnostic & Eye Centre Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 15-11-2024
- Paid Up Capital ₹ 5.12 M
as on 15-11-2024
- Company Age 33 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.39 Cr
as on 15-11-2024
- Revenue -41.26%
(FY 2023)
- Profit -8.15%
(FY 2023)
- Ebitda 145.34%
(FY 2023)
- Net Worth -21.65%
(FY 2023)
- Total Assets -23.70%
(FY 2023)
About Suraksha Diagnostic & Eye Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 5.12 M.
The company has closed loans amounting to ₹4.39 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Somnath Chatterjee, Gautam Ghosh, Tandra Chatterjee, and Five other members serve as directors at the Company.
- CIN/LLPIN
U85110WB1991PTC052153
- Company No.
052153
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Suraksha Diagnostic & Eye Centre?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Somnath Chatterjee  | Director | 27-Jun-1991 | Current |
| Gautam Ghosh | Director | 27-Jun-1991 | Current |
| Tandra Chatterjee | Director | 27-Jun-1991 | Current |
| Vishal Kejriwal | Director | 01-Apr-2009 | Current |
| Seema Kejriwal | Director | 01-Apr-2009 | Current |
| Raman Kejriwal | Director | 03-May-2024 | Current |
Financial Performance and Corporate Structure Insights of Suraksha Diagnostic & Eye Centre.
Suraksha Diagnostic & Eye Centre Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.26% decrease. The company also saw a slight decrease in profitability, with a 8.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suraksha Diagnostic & Eye Centre?
In 2023, Suraksha Diagnostic & Eye Centre had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Asian Institute Of Immunology & Rheumatology LlpActive 1 year 5 months
Somnath Chatterjee is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 10 Feb 2011 | ₹2.06 Cr | Satisfied |
Abn Amro Bank N V Creation Date: 17 Feb 2010 | ₹5.45 M | Satisfied |
Ge Capital Services India Creation Date: 01 Jun 2009 | ₹3.30 M | Satisfied |
How Many Employees Work at Suraksha Diagnostic & Eye Centre?
Unlock and access historical data on people associated with Suraksha Diagnostic & Eye Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suraksha Diagnostic & Eye Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suraksha Diagnostic & Eye Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
